Lucentis improves vision in patients with wet age-related macular degeneration
The study successfully reached its primary endpoints and reported unprecedented results in maintaining and/or improving vision for 13 patients with wet age-related macular degen...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
